1. Home
  2. TPCS vs LSTA Comparison

TPCS vs LSTA Comparison

Compare TPCS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • LSTA
  • Stock Information
  • Founded
  • TPCS 1956
  • LSTA 1980
  • Country
  • TPCS United States
  • LSTA United States
  • Employees
  • TPCS N/A
  • LSTA N/A
  • Industry
  • TPCS Metal Fabrications
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • TPCS Industrials
  • LSTA Health Care
  • Exchange
  • TPCS Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • TPCS 31.5M
  • LSTA 31.2M
  • IPO Year
  • TPCS N/A
  • LSTA N/A
  • Fundamental
  • Price
  • TPCS $3.12
  • LSTA $2.66
  • Analyst Decision
  • TPCS
  • LSTA Strong Buy
  • Analyst Count
  • TPCS 0
  • LSTA 1
  • Target Price
  • TPCS N/A
  • LSTA $15.00
  • AVG Volume (30 Days)
  • TPCS 23.2K
  • LSTA 71.7K
  • Earning Date
  • TPCS 01-21-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • TPCS N/A
  • LSTA N/A
  • EPS Growth
  • TPCS N/A
  • LSTA N/A
  • EPS
  • TPCS N/A
  • LSTA N/A
  • Revenue
  • TPCS $33,182,059.00
  • LSTA N/A
  • Revenue This Year
  • TPCS N/A
  • LSTA N/A
  • Revenue Next Year
  • TPCS N/A
  • LSTA N/A
  • P/E Ratio
  • TPCS N/A
  • LSTA N/A
  • Revenue Growth
  • TPCS 6.44
  • LSTA N/A
  • 52 Week Low
  • TPCS $2.85
  • LSTA $2.19
  • 52 Week High
  • TPCS $5.95
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 46.13
  • LSTA 42.39
  • Support Level
  • TPCS $3.06
  • LSTA $2.45
  • Resistance Level
  • TPCS $3.25
  • LSTA $2.95
  • Average True Range (ATR)
  • TPCS 0.14
  • LSTA 0.32
  • MACD
  • TPCS 0.00
  • LSTA -0.07
  • Stochastic Oscillator
  • TPCS 50.00
  • LSTA 17.61

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: